Searched for
NEGATIVE EARNINGS ALERTS
Six companies, six tricks in Indian balance sheets, and how investors get taken for a rideWhenever an Indian company imports goods, borrows in foreign currency, earns overseas revenue, or runs a foreign subsidiary, forex accounti...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27%The US-Iran peace deal is finally about to happen. There is a high probability that global markets will see a relief rally, a part of which...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- JP Morgan warns of FY27 earnings risk, says Nifty can fall to 20,500 in bear caseJP Morgan has cautioned that India’s FY27 earnings face significant risks from an extended energy and logistics shock linked to the Middle ...
- In volatile times: 5 stocks with score improvement and upside potential of up to 24%There are reasons to expect more volatility in the short term. The Street will adjust to the likely decline of both the top and bottom line...
- US stock market crashes today: What’s happening with Dow Jones, S&P 500 and Nasdaq as $200 billion vanishes in minutes from US stocks - Dow plunges 565 points, all sectors sink while oil surges with WTI up 3.4% and Brent jumping 5%US stock market crashes today. Investors are asking what’s happening with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite. ...
- BofA Securities cuts Nifty earnings target to 8.5%, says market not in value zoneBofA Securities has significantly lowered its earnings growth forecast for Nifty 50 companies to 8.5% for FY27, citing rising stagflation r...
- Global Markets | China's stock bull run falters with earnings set to underwhelmChinese stocks face a gloomy outlook as corporate earnings show a significant downturn. Investors are concerned that upcoming holiday spend...
- Negatives mostly priced in for tier 1 IT companies; correction likely in midcaps: Sunny AgrawalThe IT sector is facing a weak demand environment due to clients seeking productivity gains through Gen-AI and expecting cost benefits. Whi...
- Australia shares give up early gains as energy, tech stocks weighThe S&P/ASX 200 index settled 0.1 per cent lower at 6,745.4, after gaining as much as 0.5 per cent in earlier trading.
- Why it just may be the right time to start buying Sun PharmaThe Sun Pharma stock is down 44% from its record high of Rs 1,200 hit in April 2015. There is limited room for the stock price to sustain a...
- 5 global brokerages slash Sun Pharma targetsTop brokerages have scaled down their 12-month target price and EPS estimates for Sun Pharma, after the firm received a warning letter from...
- Sun Pharma shares a good buy despite short-term painStock may see a sell-off on earnings downgrades & FDA warning, but co has not revised revenue guidance & FIs have steadily raised holdings.
- Hike in excise duty on fuel unlikely to impact OMCs: Gautam Sinha Roy, Motilal Oswal AMC LtdIndia has simply stood out in the emerging markets pack, both from currency perspective as well as market perspective, says Gautam Sinha Ro...
- Should investors buy Ipca Labs after sharp fall?As Ipca falls over 12% following import alerts for its manufacturing units, analysts feel it will take long time for the co to resolve issu...
- Sensex rangebound, Nifty holds 7700 levels"Market will speculate on what Prime Minister Narendra Modi's big announcements will be in his maiden Independence Day address," said an II...
- Sun Pharma tanks nearly 9% in two sessions on USFDA import alertShares of Sun Pharma continued to remain under pressure for second straight session after the USFDA issued an Import Alert to its plant.
- Brokerages lower Wockhardt's target price after USFDA import alert on Chikalthana plantThe USFDA import alert on Wockhardt's second plant will have a negative impact on the pharma major, say brokerages.
- Is it time to start buying beaten down Wockhardt?Shares of Wockhardt have been beaten down badly after the company received a warning by the USFDA.
- Buy Lupin from medium-long term perspective: Avinash Gorakshekar"Typically from a medium to longer term perspective Lupin is a buy. We have a target price of Rs.500."
Load More
